Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Asthma
Location: United States, TX
Infants and toddlers with asthma symptoms (coughing, wheezing, shortness of breath).
A safety, efficacy, and tolerability study of daily dosing with levalbuterol tartrate HFA MDI and placebo in subjects aged birth to <48 mom with asthma.
Patient Inclusion Criteria:
- Subjects aged 0 to less than 48 months with asthma.
- Subject parents or legal guardian able and willing to comply with the study procedures and visit schedule.
Patient Exclusion Criteria:
- Subject with cystic fibrosis.
- Subject who was born prematurely, defined as less than 38 weeks gestational age at birth, and is less than 1 year of age.
Nancy Canada, LVN, CCRC, Study Coordinator
Allergy Asthma Research Institute
333 Londonderry Drive, Suite #110
Waco, TX 76712
Phone: 254-751-1144, option 11
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these